Tirzepatide GLP-1/GIP Peptide Vial Lyophilisate For Lab Research

What is Tirzepatide?

Tirzepatide is a synthetic dual-agonist peptide that simultaneously targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism of action makes it a uniquely potent subject of research in metabolic science, offering insights into glucose regulation, insulin secretion, and energy homeostasis that neither receptor pathway provides alone.

Key Research Areas

• Metabolic Research — Dual GLP-1/GIP receptor agonism studied for its effects on glucose metabolism and insulin sensitivity
• Obesity & Energy Homeostasis — Investigated for its role in appetite regulation and body weight management in research models
• Pancreatic Function — Explored for its effects on beta-cell function and insulin secretion dynamics
• Cardiovascular Research — Studied for potential cardioprotective effects associated with improved metabolic parameters
• Type 2 Diabetes Models — Investigated as a research tool in preclinical models of insulin resistance and glucose dysregulation

Product Details

• Quantity: 5mg per vial
• Form: Lyophilisate (lyophilized powder)
• Intended for research purposes only